Skip to main content

Closed

HAE: Haemonetics Corporation Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Operating margin18.2%

ROIC8.7%

Financially safe

Strong

Debt / equity1.54×

Interest coverage9.8×

Current ratio2.95×

Valuation

Unrated

P/E ratio41.6×

Haemonetics Corporation

HAENew York Stock Exchange·USD·Closed

Haemonetics Corporation

HAENew York Stock Exchange·USD·Closed

$85.54

+0.85%

$85.54

+$0.72 (0.85%)

52W Range

96thpctl

Volume

0.75×avg

Mkt Cap

3.89BUSD

P/E

41.6TTM

Div Yield

–ann

52W Range

96thpctl

Volume

0.75×avg

Market Cap

3.89BUSD

P/E Ratio

41.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings